Lipoxin A4

(Synonyms: LXA4)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.

For research use only. We do not sell to patients.

  • Purity: 98.0%
  • CAS No.: 89663-86-5
  • Formula: C20H32O5
  • Molecular Weight:352.47
  • Storage:

    Solution, -20°C, 1 year

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Lipoxin A4

More

All Endogenous Metabolite Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00